Related Experiment Videos
Chronic granulomatous disease: diagnosis and classification at the molecular level
P J Hopkins1, L S Bemiller, J T Curnutte
1Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla.
Insights
Chronic granulomatous disease (CGD) is a phagocyte disorder where immune cells fail to produce oxygen-based antimicrobial compounds. Understanding CGD
Area of Science:
- Immunology
- Genetics
- Infectious Diseases
Background:
- Chronic granulomatous disease (CGD) is a primary immunodeficiency.
- It stems from defective phagocyte oxidative burst, impairing pathogen killing.
- CGD is crucial in diagnosing recurrent infections.
Purpose of the Study:
- To review the clinical, biochemical, and molecular genetic aspects of CGD.
- To highlight CGD's role in the differential diagnosis of recurrent infections.
Main Methods:
- Review of existing literature on CGD.
- Synthesis of clinical, biochemical, and genetic data.
- Analysis of diagnostic considerations.
Main Results:
- CGD is characterized by a lack of microbicidal reactive oxygen species production.
- The disorder presents with specific clinical manifestations and biochemical findings.
- Molecular genetic analysis reveals various causative mutations.
Conclusions:
- CGD is a well-defined phagocyte disorder with significant implications for recurrent infections.
- Comprehensive understanding of clinical, biochemical, and genetic factors is essential for diagnosis and management.
Abstract:
Chronic granulomatous disease (CGD) is caused by the failure of phagocytes to produce microbicidal derivatives of molecular oxygen, such as hydrogen peroxide. It is one of the best characterized of the phagocyte disorders and represents an important consideration in the differential diagnosis of recurrent infections. The clinical, biochemical, and molecular genetic aspects of CGD are reviewed in this context in this article.